STRATEC SE — Investor Presentation 2020

Apr 2, 2020

STRATECFY 2019 FINANCIAL RESULTS

Conference Call – April 2, 2020

Forward-looking statements involve risks.

This company presentation contains various statements concerning the future performance of STRATEC. These statements are based on both assumptions and estimates. Although we are convinced that these forward-looking statements are realistic, we can provide no guarantee of this. This is because our assumptions involve risks and uncertainties which could result in a substantial divergence between actual results and those expected.

It is not planned to update these forward-looking statements.

1. FY 2019 AT A GLANCE

• 1. FINANCIAL REVIEW
• 1. OUTLOOK
• 1. Q&A
• 1. APPENDIX

FY 2019 AT A GLANCE

• • Dynamic sales growth of 18.0% yoy to € 221.6 million (new record high) Growth of 15.6% yoy at constant currency 2019 guidance "growth of at least 12%"
• • Adjusted EBIT up by 19.1% yoy to € 31.2 million
• Adjusted EBIT margin at 14.1% (2018: 13.9%) 2019 guidance "around 14% -15%"
• • Successful market launches by our partnersFACSDUET™ by Becton Dickinson and LIAISON® XS by DiaSorin
• •Significant progress within major development projects
• • Plan to propose a further dividend increase to a new record level of € 0.84 per share for approval by our shareholders (previous year: € 0.82)
• •Number of employees up by 6.0% yoy to 1,302 organic growth of 8.4%

1. FY 2019 AT A GLANCE

2. FINANCIAL REVIEW

• 1. OUTLOOK
• 1. Q&A
• 1. APPENDIX

FINANCIALS AT A GLANCE

€ 0 0 0s	2 0 9 1	3 2 0 8 1	C ha ng e
Sa les	2 2 1, 6 4 1	1 8 7, 8 2 0	1 8. 0 % +
A T A d d E B I D j te us	4 0, 8 3 5	3 6, 9 0 1	2. 9 % 1 +
A d d E B I T D A ( % ) j in te us m ar g	1 8. 4	1 9. 3	9 0 bp s -
A d d E B I T j te us	3 0 1, 1 5	2 6, 1 5 7	9. % 1 1 +
A d d E B I T ( % ) j in te us m ar g	1 4. 1	1 3. 9	2 0 bp + s
4 A d d l da d j i inc te te t us co ns o ne om e	2 5, 8 9 6	2 0, 2 3 8	2 8. 0 % +
4 A ( € ) d d ba ha j ic ing in te us s ea rn s p er s re	2. 6 1	0 1. 7	2 % 7. 1 +
4 Ba ha I F R S ( € ) ic ing in s ea rn s p er s re	1. 3 4	0. 9 3	4 4. 1 % +
D de d S ha ( € ) iv i in n p er re	2 0. 8 4	0. 8 2	2. 4 % +

bps = basis points

¹ For comparison purposes, adjusted figures exclude amortization resulting from purchase price allocations in the context of acquisitions and the associated reorganization expenses, as well as other non-recurring effects.

² Planned and subject to approval by the Annual General Meeting.

³ Not retrospectively restated for IFRS 16.

⁴ Results from continuing operations.

SALES

Sales in € million

As of December 31

FY 2019 sales up 18.0% yoy to € 221.6 million; +15.6% at constant currency

• • Increased sales with development and services
• Achievement of significant development targets
• • Strong call-up numbers for established as well as recently launched systems
• • Higher sales with service parts and consumables
• Pleasing utilization rates in the installed system base

SALES BY OPERATING DIVISIONS

Others

In % of total sales

Development and services

As of December 31

ADJUSTED EBIT AND EBIT MARGIN

FY 2019 EBIT up 19.1% yoy to € 31.2 million

Adjusted EBIT margin up by 20 bps yoy to 14.1%

(+) Economies of scales

• (+) Positive results from earnings improvement initiative
• (-) Product/sales mix
• (-) Stock appreciation rights (negative margin effect of 40 bps)

As of December 31

SEGMENT PERFORMANCE

Instrumentation

€ 0 0 0s	2 0 1 9	2 0 1 8	C ha ng e
Sa les	1 5 4, 4 4 2	3 3 3 1 1, 2	% 1 7. 6 +
A d d E B I T j te us	2 2, 0 0 5	2 0, 9 9 3	4. 8 % +
A d d E B I T ( % ) j in te us ma rg	1 4. 2	1 6. 0	-1 8 0 bp s

Adverse margin effect from higher share of lower margin development and services sales

Smart Consumables

€ 0 0 0s	2 0 1 9	2 0 1 8	C ha ng e
Sa les	1 6, 8 3 5	1 6, 7 6 5	0. 4 % +
A d d E B I T j te us	2 4 -1 5 ,	9 9 1	2 6 % -7 5.
% A d d E B I T ( ) j in te us ma rg	-7 4	1. 2	-8 6 0 bp s

Adverse margin effects due to high development activities for blue chip players

Diatron

€ 0 0 0s	2 0 1 9	2 0 1 8	C ha ng e
Sa les	4 2, 8 8 0	3 3 4 5, 1	2 3 % 1. +
A d d E B I T j te us	8, 3 5 3	4, 6 8 5	7 8. 3 % +
A d d E B I T ( % ) j in te us ma rg	1 9. 5	1 3. 3	6 2 0 bp + s

New product launches and strong business with veterinary products

O h t e r s
€ 0 0 0s	2 0 1 9	H 1 / 2 0 1 8	C ha ng e
Sa les	7. 4 8 5	4. 3 9 1	7 0. 5 % +
A d d E B I T j te us	2. 0 3 7	2 8 7	6 3 2. 7 +
( % ) A d d E B I T j in te us ma rg	2 2 % 7.	6. 3 %	+2 0 9 0 b ps ,

Recognition of development and services sales with above average profitability

CASH FLOW AND NET DEBT

€ 0 0 0s	2 0 9 1	2 0 8 1	C ha ng e
Ca h f lo ing iv i ies t t t s w op er a a c –	2 1. 3	1 2. 0	7 7. 5 % +
Ca h f lo inv iv i ies tm t a t t s w es en c –	2 7. 7 -	1 0. 8 -	nm
Ca h f lo f ina ing iv i ies t t s w nc a c –	5. 5	0. 9 -	nm
Fr h f lo ee c as w	6. 4 -	1. 2	nm

€ 0 0 0s	2 0 1 9	2 0 1 8	C ha ng e
Ca h d h len iva ts s an ca s eq u f p d d io t e a n er o	2 2. 7	2 3. 8	4. 6 % -
Eq ( % ) i io ty t u ra	5 3. 1	5 5. 3	2 2 0 bp s -
N de b t t e	7 7. 3	5 3. 1	4 5. 4 % +

• • Cash flow from operating activities up 77.5% yoy to € 21.3 million
• -Strong development in Q4
• -Adverse effects from higher tax payments
• • Higher investment spending due to significant capacity expansion at HQ (i.e. capacity expansion for development and prototyping) and high development activities
• • Investment ratio¹ of 12.1% of sales2019 guidance 12% - 14%
• • Higher net debt position driven by financing of capex investments and first time adoption of IFRS 16

1 Total investments in intangible and tangible assets in % of sales

1. FY 2019 AT A GLANCE

1. FINANCIAL REVIEW

3. OUTLOOK

• 1. Q&A
• 1. APPENDIX

FINANCIAL GUIDANCE FOR FISCAL YEAR 20201

• •Group sales expected to increase in a high single-digit percentage range²
• • Adjusted EBIT margin of around 15% (2019: 14.1%)
• Positive scale effects; defined earnings improvement measures; improving sales and product mix
• • Investments in tangible and intangible assets of around 10% to 12% of sales
• Ongoing construction measures for significant capacity expansion
• After completion of construction projects for capacity expansion, investment ratio is likely to decline further in 2021

1 Most recently, STRATEC witnessed an upward trend in orders and order forecasts as a result of the coronavirus pandemic. However, the implications of the pandemic, including potential effects on the supply chain and any temporary interruptions in production arising as a result, currently cannot be predicted in full and have therefore not been factored into the above outlook.

2 Sales growth at constant currency

OUTLOOK

FOCUS IN 2020 AND BEYOND

•Manage challenges arising from coronavirus pandemic

• Health of our employees has highest priority
• Deliver on received extra orders and support customers in making their contribution in the fight against the pandemic
• Mitigate and manage supply chain risks
• •Improve EBIT contribution of Smart Consumables segment
• •Achievement of development targets
• • Introduction of new products
• Expected launches among others in 2020 include a proprietary analyzer platform and various stand-alone modules/components
• •Sign new development and supply agreements (execute deal pipeline)
• •Realize further efficiency gains (earnings improvement initiative, ERP system implementation)

QUESTIONS& ANSWERS

FY 2019 FINANCIAL RESULTS – APRIL 2, 2020 ¹⁵

APPENDIX

ADJUSTMENTS

EBIT

€ 0 0 0s	2 0 1 9
A d j d E B I T te us	3 1, 1 5 0
A d j tm ts us en :
P P A iza io t t am or n	-8 9 9 6 ,
Tr lat d d a d io iat ct an sa n- re e ex p en se s a n sso c e ing str tu re uc r ex p en se s	-3 0 7 5 ,
E B I T	9, 0 9 1 7

Consolidated net income

€ 0 0 0s	2 0 1 9
A d j d l i da d in fro te te t us co ns o ne co m e m in in io t t co n u g op er a ns	2 8 9 6 5,
j in fro A d d ha te us ea rn g s p er s re m in in io in € ( ba ic ) t t co n u g op er a ns s	2. 1 6

Adjustments:

P P A iza io t t am or n	-8 9 9 6 ,
Tr lat d d a d io iat ct an sa n- re e ex p en se s a n sso c e ing str tu re uc r ex p en se s	-3 0 7 5 ,
Cu nt tax rre ex p en se s	8 3 3
De fe d t inc rre ax om e	1, 4 3 0
Co l i da d in fro in in te t t ns o ne co m e m co n u g io t op er a ns	6, 0 8 8 1
in fro in in Ea ha t rn g s p er s re m c on u g io in € ( ba ic ) t op er a ns s	3 4 1.

CONTACT

STRATEC SEGewerbestr. 3775217 BirkenfeldGermany

www.stratec.com

CONTACT

Marcus WolfingerCEO

Jan Keppeler, CFA Head of Investor Relations & Corporate Communications

Phone +49 7082 7916-6515 j.keppeler@stratec.com

FY 2019 FINANCIAL RESULTS – APRIL 2, 2020 ¹⁷